[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 50.16.107.222. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
October 1995

Suicidal Behaviors and the Tryptophan Hydroxylase Gene

Author Affiliations

From the Department of Psychiatry (Drs Abbar, Amadéo, Caer, and Castelnau and Mr Courtet), University of Montpellier—Nîmes (France), Laboratory of Molecular Genetics of Neurotransmission, Centre National de la Recherche Scientifique (CNRS UMR 9923), Gif-sur-Yvette, France (Dr Mallet), and Institut National de la Santé et de la Recherche Médicale U 249 (CNRS UPR 9008), Montpellier (Drs Baldy-Moulinier and Malafosse). Dr Malafosse is now with the Neuropsychiatry Division, University Hospital of Psychiatry, Geneva, Switzerland.

Arch Gen Psychiatry. 1995;52(10):846-849. doi:10.1001/archpsyc.1995.03950220056011
Abstract

Background:  To determine whether the tryptophan hydroxylase gene (ie, the gene that codes for the rate-limiting enzyme in the metabolic pathway of serotonin) may be a susceptibility factor for suicidal behavior.

Methods:  Genotypic and allelic frequencies at a polymorphic Ava II restriction site were revealed with the use of the complementary DNA tryptophan hydroxylase probe C2-38 in 62 suicide attempters. The psychiatric characteristics of these suicide attempters were determined using the Schedule for Affective Disorders and Schizophrenia—Lifetime version with modification for the study of anxiety disorders, and these characteristics were compared with those in 52 healthy controls.

Results:  No association between tryptophan hydroxylase and suicidal behavior was detected.

Conclusion:  The tryptophan hydroxylase gene was not a susceptibility factor for suicidal behaviors in the group of suicide attempters in this study.

×